MicroMed Technology Company
%20.jpg)
According to American Heart Association statistics, 20,000-40,000 patients in the United States would benefit from a heart transplant. The MicroMed DeBakey VAD®, jointly developed with Dr. Michael DeBakey, Dr. George Noon and the National Aeronautics and Space Administration (NASA), has the potential to keep many of these people alive until a donor heart becomes available. Weighing less than four ounces, the device is silent and is approximately 1/10 the size of other pulsatile products on the market. The MicroMed DeBakey VAD® is designed to be a lower-cost, less invasive alternative to the commercially available, larger ventricular assist devices (VADs).
%20.jpg)
Technology:
Regenerative Medicine
Headquarters:
Houston, Texas, United States
Funding Status:
Late Stage Venture
Founded Date:
1998-11-01
Last Funding Type:
Series D
Investors Number:
6
Total Funding:
$40.6M
Industry:
Health Care, Medical Device, Wellness
Investor Type:
For Profit